Menu
Search
Home > Courses > Update on Anal Cancer Prevention, Screening, Treatment and Observation in HIV Medicine

Update on Anal Cancer Prevention, Screening, Treatment and Observation in HIV Medicine

Update on Anal Cancer Prevention, Screening, Treatment and Observation in HIV Medicine
Play
Sorry, this learning module is not available for mobile devices.
Original Release Date: 10/15/2019
Termination Date: 10/14/2022
Review Date: 1/13/2020
Presenter
  • Stephen E. Goldstone, MD, FACS
    Assistant Clinical Professor of Surgery
    Mount Sinai School of Medicine
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Be aware of the progression rates of AIN3 to invasive anal cancer.
  2. Know who is at risk for progression.
  3. Understand the problems of close follow-up for patients with AIN3.
  4. Appreciate the possible utility of HPV testing as a tool when screening for anal dysplasia.
Presenter Bio
Stephen Goldstone, MD, FACS
Stephen E. Goldstone is an Assistant Clinical Professor of Surgery at The Icahn School of Medicine at Mount Sinai and has a surgical practice in New York City. Dr. Goldstone has spoken at conferences around the world and has done extensive research on human papillomavirus (HPV). His work has been published in many prestigious medical journals, and is currently involved in testing both prevention and treatment procedures for HPV. He is a past-president of the International Anal Neoplasia Society and a member of the AIDS Malignancy Consortium.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit on October 15, 2019 and will terminate October 14, 2022.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

 Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Stephen E. Goldstone, MD, FACS (Presenter) had the following personal financial relationships in the prior 12 months with manufacturers of the products or services that may be presented in this CME activity: Investigator for Merck, Antiva, Inovio, and Metronic; Speaker at Merck; Consultant to Merck, and THD America. Dr. Goldstone submitted his slides in advance for adequate peer review. And will support his presentation and clinical recommendations with the best available evidence from the medical literature.

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Gilead Sciences, Janssen Therapeutics (a division of Janssen Products, LP), Merck & Co., and ViiV Healthcare.

Details: 

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules